COVID-19–Associated Collapsing Glomerulopathy: An Emerging Entity
Authors:
Open Access
- 1 June 2020
- journal article
- editorial
- Published by Elsevier in Kidney International Reports
- Vol. 5 (6) , 759-761
Abstract
No abstract availableFunding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (ZO1-DK043308)
This publication has 8 references indexed in Scilit:
- Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?Journal of Autoimmunity, 2020
- Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in ChinaKidney International, 2020
- Kidney disease is associated with in-hospital death of patients with COVID-19Kidney International, 2020
- The Novel Coronavirus 2019 epidemic and kidneysKidney International, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Histopathology of Middle East respiratory syndrome coronovirus (MERS‐CoV) infection – clinicopathological and ultrastructural studyHistopathology, 2017
- Focal Segmental GlomerulosclerosisNew England Journal of Medicine, 2011
- Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signalingNature Medicine, 2011